Genetic factors play a crucial role in the development of non-insulin-dependent diabetes mellitus (NIDDM). However, efforts to identify NIDDM genes have not been successful because of NIDDM's complexity and heterogeneity. As a new strategy for finding NIDDM genes, this project will investigate early-onset, autosomal dominant NIDDM - a subtype of diabetes that is more strongly determined by genetic factors than common NIDDM but, like common NIDDM, is characterized by the presence of insulin-resistance. Using a large panel of informative families manifesting this type of diabetes, NIDDM genes will be searched by means of two complementary approaches: 1. genome-wide screening, and 2. studies of candidate genes. DNA and clinical information are already available at the Joslin Diabetes Center for most of these families. A 10 cM genome screen for linkage with NIDDM will be performed using a novel DNA pooling technique which requires a smaller genotyping effort than traditional methods. Linkage with NIDDM will be also evaluated for candidate genes coding for both known and newly identified proteins involved in insulin action (IRS-2, IRS-3, IRS-4, PI-3-kinase, SHP-2, Grb-2, Shc, GRB-1Rbeta, and several other newly identified SH2 proteins expressed in skeletal muscle). Linkage with NIDDM will be evaluated by both parametric and non-parametric methods. Genes located in the chromosomal regions identified by the genome screen, as well as candidate genes found to be linked with NIDDM, will be screened for mutations. The investigators note that identification of genes that are responsible for the development of early-onset NIDDM will have a profound impact on research on insulin action that are involved in the development of insulin-resistance, with clear implications for studies of the etiology of NIDDM and the development of drugs to treat insulin resistance.
| Kawamori, Dan; Shirakawa, Jun; Liew, Chong Wee et al. (2017) GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in ?IRKO mice. Diabetologia 60:1442-1453 |
| Shirakawa, Jun; Fernandez, Megan; Takatani, Tomozumi et al. (2017) Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic ? Cell Proliferation. Cell Metab 25:868-882.e5 |
| Teo, Adrian Kee Keong; Lau, Hwee Hui; Valdez, Ivan Achel et al. (2016) Early Developmental Perturbations in a Human Stem Cell Model of MODY5/HNF1B Pancreatic Hypoplasia. Stem Cell Reports 6:357-67 |
| El Ouaamari, Abdelfattah; Dirice, Ercument; Gedeon, Nicholas et al. (2016) SerpinB1 Promotes Pancreatic ? Cell Proliferation. Cell Metab 23:194-205 |
| Valdez, Ivan Achel; Dirice, Ercument; Gupta, Manoj K et al. (2016) Proinflammatory Cytokines Induce Endocrine Differentiation in Pancreatic Ductal Cells via STAT3-Dependent NGN3 Activation. Cell Rep 15:460-470 |
| Teo, Adrian Kee Keong; Gupta, Manoj K; Doria, Alessandro et al. (2015) Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools. Mol Metab 4:593-604 |
| Prudente, Sabrina; Jungtrakoon, Prapaporn; Marucci, Antonella et al. (2015) Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus. Am J Hum Genet 97:177-85 |
| Valdez, Ivan A; Teo, Adrian K K; Kulkarni, Rohit N (2015) Cellular stress drives pancreatic plasticity. Sci Transl Med 7:273ps2 |
| Mezza, Teresa; Kulkarni, Rohit N (2014) The regulation of pre- and post-maturational plasticity of mammalian islet cell mass. Diabetologia 57:1291-303 |
| Bernal-Mizrachi, Ernesto; Kulkarni, Rohit N; Scott, Donald K et al. (2014) Human ?-cell proliferation and intracellular signaling part 2: still driving in the dark without a road map. Diabetes 63:819-31 |
Showing the most recent 10 out of 44 publications
